Trial intelligence / Profile preview

Cannabidiol cream for vestibulodynia pain relief

ISRCTN78323046Phase 4Completed

Sponsor
Ospedale dei Bambini Vittore Buzzi
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in vestibulodynia and vulvodynia comparing Cannabidiol gel with Placebo gel (2 arms). Primary endpoints: Pain intensity, Dyspareunia and 3 more. Started Mar 2025; status: completed.

02

Drugs

cannabidiol
03

Conditions

vestibulodyniavulvodynia

Beyond the preview

Go deeper on ISRCTN78323046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN78323046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call